BRIEF—Vicore appoints new chief executive

Sweden's Vicore Pharma will install Ahmed Mousa as chief executive, replacing outgoing CEO Carl-Johan Dalsgaard, who is retiring.

Mr Mousa joins Vicore from Pieris Pharmaceuticals, where he served as chief business officer, executing a series of major strategic partnerships, helping advance multiple therapeutic programs from concept to clinical studies.

Vicore is seeking to advance its lead candidate C21 to late-stage development, following positive data from the Phase IIa AIR trial in idiopathic pulmonary fibrosis.

Mr Mousa said it was “a pivotal moment” for the company, adding: “I am impressed by the progress made by Vicore and look forward to working with such a stellar team to advance C21 and the broader pipeline.”